Antibody-Based Protein Multiplex Platforms: Technical and Operational Challenges

Abstract

BACKGROUND:The measurement of multiple protein biomarkers may refine risk stratification in clinical settings. This concept has stimulated development of multiplexed immunoassay platforms that provide multiple, parallel protein measurements on the same specimen. CONTENT:We provide an overview of antibody-based multiplexed immunoassay platforms and discuss technical and operational challenges. Multiplexed immunoassays use traditional immunoassay principles in which high-affinity capture ligands are immobilized in parallel arrays in either planar format or on microspheres in suspension. Development of multiplexed immunoassays requires rigorous validation of assay configuration and analytical performance to minimize assay imprecision and inaccuracy. Challenges associated with multiplex configuration include selection and immobilization of capture ligands, calibration, interference between antibodies and proteins and assay diluents, and compatibility of assay limits of quantification. We discuss potential solutions to these challenges. Criteria for assessing analytical multiplex assay performance include the range of linearity, analytical specificity, recovery, and comparison to a quality reference method. Quality control materials are not well developed for multiplexed protein immunoassays, and algorithms for interpreting multiplex quality control data are needed.

Development of a custom pentaplex sandwich immunoassay using Protein-G coupled beads for the Luminex® xMAP® platform

“…), which is of particular importance if a scientific question relies on a combination of biomarkers or the relationships between them (Lewczuk, 2012). Furthermore, bead-based assays can detect raw imprecision of repeated (duplicate) measurements (Lewczuk, 2012), and also offer improved imprecision because multiple, independent measurements (typically 50-100) are carried out within each bead region (Ellington et al, 2010).…”

Simple Plex™: A Novel Multi‐Analyte, Automated Microfluidic Immunoassay Platform for the Detection of Human and Mouse Cytokines and Chemokines

“…Immunoassays are the most common quantitative approach used and have been extensively characterized in terms of sensitivity, reproducibility, and variability 4, 5. However, due to labor intensity existing immunoassays are not practical for the evaluation of multiple proteins, nor are they cost‐effective 4.…”

Testes sanguíneos de biomarcadores para diagnóstico e tratamento de desordens mentais: foco em esquizofrenia

“…Development of multiplexed immunoassays for example requires validation of the assay structure and analytical performance to maximize precision and accuracy. In this case, the associated challenges include selection and immobilization of capture ligands, calibration, reagent-antibody compatibility, dynamic range and limits of detection 68 .…”